Abstract
Primary lymphoma of the breast is very rare especially in a male patient. Treatment alternatives include surgery, chemotherapy, immunotherapy and radiation. It is still controversial which combination is the best. Here, we report a male patient who presented with a left breast mass. The excisional biopsy was applied, and pathological assessment revealed marginal zone lymphoma. Both conventional computed tomography and 18)F-Fluorodeoxyglucose positron emission tomography/computed tomography were used for staging. The clinical stage was IIE for Ann Arbor staging and so local radiation following chemo immunotherapy was planned. Left-sided primary breast lymphoma in a male patient is a very rare entity. Treatment modalities are still controversial. Some authors believe that primary breast lymphomas have poor prognosis, and they must be treated aggressively with combined treatment modalities. Another important point is that 18)F-Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET)/CT could be used for staging of disease and assessing treatment response in a patient with primary breast marginal zone lymphoma.
Similar content being viewed by others
References
Brogi E, Harris NL. Lymphomas of the breast: pathology and clinical behavior. Semin Oncol. 1999;26:357–64.
Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of etranodal lymphomas. Cancer. 1972;29:252–60.
Misra A, Kapur BML, Rath GK. Primary breast lymphoma. J Surg Oncol. 1991;47:265–70.
Mattia AR, Ferry JA, Harris NL. Breast lymphoma: a B-cell spectrum including the low grade B-cell lymphoma of mucosa associated lymphoid tissue. Am J Surg Pathol. 1993;17:574–87.
Wiseman C, Liao KT. Primary lymphoma of the breast. Cancer. 1972;29:1705–12.
Mambo NC, Burke JS, Butler JJ. Primary malignant lymphoma of the breast. Cancer. 1977;39:2033–40.
Barışta İ, Baltalı E, Tekuzman G, Kars A, Ruacan Ş, Özışık F, et al. Primary breast lymphomas. A retrospective analysis of twelve cases. Acta Oncol. 2000;39(2):135–9.
Suarez F, Lortholary O, Hermine O, Lecuit M. Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood. 2006;107(8):3034–44.
Elstrom R, Guan L, Baker G, Nakhoda G, Vergilio JA, Zhuang H, et al. Utility of FDG-PET scanning in lymphoma by WHO classification. Blood. 2003;101:3875–6.
Kumar R, Maillard I, Schuster SJ, Alavi A. Utility of fluorodeoxyglucose-PET imaging in the management of patients with Hodgkin’s and non-Hodgkin’s lymphomas. Radiol Clin North Am. 2004;42:1083–100.
Friedber JW, Chengazi V. PET scans in the staging of lymphoma: current status. Oncologist. 2003;8:438–47.
Alizarin L, Castelluci P, Elstrom R, Ambrosini V, Stefoni V, Nanni C, et al. 18 F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma. Leuk Lymphoma. 2006;47:2096–101.
Schoder H, Noy A, Gonen M, Weng L, Green D, Erdi YE, et al. Intensity of 18 fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin’s lymphoma. J Clin Oncol. 2005;23:4643–51.
Perry C, Herishanu Y, Metzer U, Bairey O, Ruchlemer R, Trejo L, et al. Diagnostic accuracy of PET-BT in patients with extranodal marginal zone MALT lymphoma. Eur J Haematol. 2007;79(3):205–9.
Von Schulthess GK, Steinert HC, Hany TF. Integrated PET/CT: current applications and future directions. Radiology. 2006;16:405–22.
Kostakoglu L, Hardoff R, Mirtcheva R, Goldsmith SJ. PET-CT fusion imaging in differentiating physiological from pathological FDG uptake. Radiographics. 2004;24:1411–31.
Wakabayashi H, Maeba T, Maeta H, Tanaka S. A case of primary malignant lymphoma of the bilateral breast. A study of surgical treatment based on the clinicopathological evaluation of its local involvement and postoperative recurrence site. Jpn J Breast Cancer. 1999;9:675–80.
Brustein S, Kimmel M, Lieberman PH, Filippa DA, Rosen PP. Malignant lymphoma of the breast: a study of 53 patients. Ann Surg. 1997;205:144–50.
Uesato M, Miyazawa Y, Gunji Y, Orchiai T. Primary Non-Hodgkin’s lymphoma of the breast report of the breast report of a case with special reference to 380 cases in the Japanese literature. Breast Cancer. 2005;12(2):15–8.
Miller TP, Dahlberg S, Robert Cassady J, Aldstein DJ, Spier CM, Grogan TM, et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate and high grade non Hodgkin’s lymphoma. N Eng J Med. 1998;339:21–6.
Tokui K, Sato M, Inoue H, Bando Y, Go S, Kimura S. A case of primary malignant lymphoma of the breast. Ehime Igaku. 1988;8:259–63.
Kim SH, Ezekiel MP, Kim RY. Primary lymphoma of the breast. Am J Clin Oncol. 1999;22:381–3.
Ryan G, Martinelli G, Kuper-Hommel M, Tsang R, Pruneri G, Yuen K, et al. Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extra nodal Lymphoma Study Group. Ann Oncol. 2009;19:233–41.
Martinelli G, Ryan G, Seymour JF, Nassi L, Steffanoni S, Alietti A, et al. Primary follicular an marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extra nodal Lymphoma Study Group. Ann Oncol. 2009 (Epub ahead of print).
Conconi A, Martinelli G, Thieblemont C, et al. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood. 2003;102:2741–5.
Giardini R, Piccolo C, Rilke F. Primary non-Hodgkin’s lymphomas of the female breast. Cancer. 1992;69:725–35.
Abbondanzo SL, Seidman JD, Lefkowitz M, Tavassoli FA, Krishnan J. Primary diffuse large B-cell lymphoma of the breast. A clinicopathological study of 31 cases. Pathol Res Pract. 1996;192:37–43.
Kuper Hommel MJ, Snijder S, Janssen-Heijnen ML, Vrints LW, Kluin-Nelemans JC, Coebergh JW, et al. Treatment and survival of 38 breast lymphomas: a population based study with clinical and pathological reviews. Ann Hematol. 2003;82:397–404.
Gholam D, Bibeau F, Weshi El, Bosq J, Ribrag V. Primary breast lymphoma. Leuk Lymphoma. 2003;44:1173–8.
Liu MT, Hsieh CY, Wang AY, Pi CP, Chang TH, Huang CC, et al. Primary breast lymphoma: a pooled analysis of prognostic factors and survival 93 cases. Ann Saudi Med. 2005;25:288–93.
Lin YC, Tsai CH, Wu JS, Huang CS, Kuo SH, Lin CW, Cheng AL. Clinicopathological features and treatment outcome of non-Hodgkin lymphoma of the breast—a review of 42 primary and secondary cases in Taiwanese patients. Leuk Lymphoma. 2009;50(6):918–20.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Duman, B.B., Şahin, B., Güvenç, B. et al. Lymphoma of the breast in a male patient. Med Oncol 28 (Suppl 1), 490–493 (2011). https://doi.org/10.1007/s12032-010-9675-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12032-010-9675-0